| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.013 | 0.8 |